(Q85736057)
Statements
Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression (English)
Pengcheng Shi
Jie Zha
Xutao Guo
Feili Chen
Zhiping Fan
Fen Huang
Fanyi Meng
Xiaoli Liu
Ru Feng